TcrossGlobal

Vascular Response to Drug-Coated vs. Drug-Eluting Stents 1 and 12 Months After Implantation: The COLLABORATION Study

The COLLABORATION study showed that in patients with coronary artery disease, the polymer-free BioFreedom Biolimus A9 Coated Stent (PF-BCS) did not differ from the Xience Everolimus-Eluting Stent (DP-EES), which uses a durable polymer, in thrombus formation at 1 month and 12 months after implantation. Although there was no difference in thrombus formation at 1 and 12 months after implantation, the strut coverage and plaque stabilization at 12 months were better. Dr. Takayuki Ishihara of Kansai Rosai Hospital presented at the Hot-line Session of the 86th Annual Meeting of the Japanese Circulation Society.

In the COLLABORATION study, four institutions (Kansai Rosai Hospital, Osaka University, Osaka Rosai...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.